Watch YDES. Know when insiders buy.
One email the day a filing lands. Free.
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $597K | 28.1% | −$5.3M | −$8.3M | -1392.6% | -0.12 | −$6.6M | $1.4M | −$8M | — | — |
| FY2024 · to Dec 31 | $510K | 30.4% | −$1.5M | −$1.4M | -276.6% | -0.02 | −$1.2M | $75K | −$1.3M | — | — |
| FY2023 · to Dec 31 | $350K | 43.8% | −$10K | $14K | 3.9% | 0.00 | −$56K | $290 | −$56K | — | — |
Every number comes from YD Bio Ltd's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.